| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1001/ARCHINTE.160.5.610 |
| P698 | PubMed publication ID | 10724046 |
| P2093 | author name string | Genta MS | |
| Janssen NM | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 610-619 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation | |
| P478 | volume | 160 |
| Q37052664 | Acute neurological issues in pregnancy and the peripartum |
| Q34986982 | Antirheumatic drugs in pregnancy |
| Q34328070 | Azathioprine for atopic dermatitis. |
| Q34184133 | Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. |
| Q37186394 | Behçet's syndrome in pregnancy. |
| Q41913969 | Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry. |
| Q38254406 | Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management. |
| Q64229185 | Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance |
| Q43089424 | Course and treatment of myasthenia gravis during pregnancy |
| Q36711722 | Dermatologic treatment during pregnancy: practical overview |
| Q34361831 | Dermatological medication effects on male fertility |
| Q42545664 | Dermatomyositis presenting with symptomatic dermographism and raised troponin T: a case report |
| Q36687466 | Drug therapy of inflammatory bowel disease in fertile women |
| Q35902580 | Eczema in pregnancy |
| Q46896220 | Effect of chronic azathioprine treatment on germ-line transmission of Hprt mutation in mice |
| Q43571901 | Effect of human chorionic gonadotrophin coadministration on ovarian steroidogenic and folliculogenic activities in cyclophosphamide treated albino rats |
| Q36751710 | Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis |
| Q28199350 | Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study |
| Q36897721 | Fertility and Contraception in Women With Inflammatory Bowel Disease |
| Q51139872 | Fertility in women with rheumatoid arthritis: influence of disease activity and medication. |
| Q51805746 | Fertility status among women treated for aggressive non-Hodgkin's lymphoma. |
| Q60953500 | Fetal Toxicity of Immunosuppressive Drugs in Pregnancy |
| Q38711611 | Identifying Key Intervention Opportunities During a Pregnancy Complicated by Diabetes: a Review of Acute Complications of Diabetes During Pregnancy |
| Q53857149 | Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants. |
| Q50672696 | Indoleamine 2,3-dioxygenase (IDO) activity in placental compartments of renal-transplanted pregnant women. |
| Q28388274 | Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review |
| Q46789817 | Leflunomide: assessing teratogenic risk during the first trimester of pregnancy |
| Q28364465 | Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes |
| Q35169341 | Managing pregnancy in inflammatory rheumatological diseases |
| Q35216314 | New insights into pregnancy-related complications in systemic lupus erythematosus |
| Q35267073 | Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation |
| Q34734826 | Nonsteroidal anti-inflammatory drugs and reversible female infertility: is there a link? |
| Q53722072 | Outcomes in mothers with rheumatic diseases and their offspring workshop. |
| Q46967156 | Parenthood in pediatric liver transplant patients |
| Q35797083 | Pregnancy and lactation |
| Q26999063 | Pregnancy following liver transplantation: review of outcomes and recommendations for management |
| Q62073566 | Pruritus in der Schwangerschaft |
| Q44031473 | Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease |
| Q36155827 | Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation |
| Q38246990 | Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation |
| Q34421471 | Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine |
| Q55025616 | Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. |
| Q36169364 | Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease |
| Q38166663 | Safety and tolerability of tumor necrosis factor-α inhibitors in psoriasis: a narrative review |
| Q31000488 | Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. |
| Q36237544 | Sulfasalazine: a review of its use in the management of rheumatoid arthritis |
| Q36405717 | Taking NSAIDs during pregnancy. Is it safe? |
| Q45023014 | The teratogenicity of dermatological treatments |
| Q37608422 | The use of antirheumatic disease drugs during pregnancy |
| Q37552947 | Therapeutic options for rheumatoid arthritis |
| Q36467833 | Therapy insight: drugs for gastrointestinal disorders in pregnant women |
| Q37011834 | Treating common ear problems in pregnancy: what is safe? |
| Q38126535 | Treatment of atopic dermatitis in pregnancy |
| Q38012490 | Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy |
| Q40224089 | Use of contraception by women treated with leflunomide due to rheumatic arthritis. |
| Q83217510 | [Drug therapy during pregnancy and breast feeding. Updated summary] |
| Q84600029 | [Treatment of systemic lupus erythematosus in the pregnant patient] |
Search more.